{
    "2021-12-06": [
        [
            {
                "time": "",
                "original_text": "医药行业周报：国谈结果出炉 政策趋于平缓",
                "features": {
                    "keywords": [
                        "国谈",
                        "政策",
                        "平缓"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业沪深港通资金医药股流向数据库",
                "features": {
                    "keywords": [
                        "沪深港通",
                        "资金流向",
                        "医药股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "2021年基金，买了个“寂寞”",
                "features": {
                    "keywords": [
                        "基金",
                        "投资回报",
                        "寂寞"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "粤开策略深度 | 医药生物行业2022年展望：价值重鸣，创新为锋",
                "features": {
                    "keywords": [
                        "医药生物",
                        "展望",
                        "价值",
                        "创新"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "凯莱英H股每股定价388港元 A/H股折价率达32%",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "H股",
                        "定价",
                        "折价率"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【最全】2022年中国肽CDMO行业上市公司全方位对比(附业务布局汇总、业绩对比、业务规划等)",
                "features": {
                    "keywords": [
                        "肽CDMO",
                        "上市公司",
                        "对比",
                        "业务规划"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "重头戏来了？青瓷游戏、商汤科技本周招股",
                "features": {
                    "keywords": [
                        "青瓷游戏",
                        "商汤科技",
                        "招股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "游戏"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：医保谈判落地 释放积极信号",
                "features": {
                    "keywords": [
                        "医保谈判",
                        "落地",
                        "积极信号"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "21健讯Daily｜医保基金飞检管理办法出台；研究发现奥密克戎有“弱病毒”基因",
                "features": {
                    "keywords": [
                        "医保基金",
                        "飞检",
                        "奥密克戎",
                        "弱病毒"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【新股IPO】凯莱英(06821)H股发售价为388港元 预计于12月10日挂牌交易",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "IPO",
                        "H股",
                        "发售价"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "港股盘前必读：滴滴启动在香港上市，多家房企启动固收产品发行",
                "features": {
                    "keywords": [
                        "港股",
                        "滴滴",
                        "香港上市",
                        "房企",
                        "固收产品"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "房地产"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "凯莱英(06821)发售价每股388港元 预期H股将于12月10日上市",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "发售价",
                        "H股",
                        "上市"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "凯莱英：香港IPO发售价厘定为每股H股股份388港元",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "香港IPO",
                        "发售价"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}